Sender Company & Partners’s Insmed INSM Stock Holding History

Sender Company & Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,166	Closed	-$218K	–	524
2025 Q2	$218K	Buy	+2,166	New	+$166K	0.06%	241

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sender Company & Partners's INSM Position: Q3 2025 in Review

Sender Company & Partners sold out of Insmed (INSM) in Q3 2025, closing a stake of 2,166 shares — an estimated $218K sold.

Sender Company & Partners first reported a position in INSM in Q2 2025 and held it in 1 quarter. The position peaked at $218K in Q2 2025. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

Sender Company & Partners reported no remaining Insmed position as of Q3 2025 after selling out during the quarter.
Sender Company & Partners sold 2,166 Insmed shares in Q3 2025, an estimated $218K.
Sender Company & Partners first reported a position in Insmed in Q2 2025 and held it in 1 quarter.
Sender Company & Partners's Insmed position peaked at $218K in Q2 2025.
566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Sender Company & Partners's 13F filing for Q3 2025, filed 17 Nov 2025.